ASP8302: Clinical Trials

2 trials of ASP8302, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1
Phase 21Completed 1

Follow ASP8302: new trials by email Literature Review of ASP8302 trials Research Report on ASP8302

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of ASP8302 in Participants With Underactive Bladder
ASP8302, Placebo - Underactive Bladder
Phase 2CompletedAstellas Pharma Europe B.V.1352018-11-202024-11-21
ASP8302 Single and Multiple Ascending Oral Dose Study in Non-elderly Healthy Japanese Subjects
ASP8302, Placebo - Healthy Subjects
Phase 1CompletedAstellas Pharma Inc562017-11-142024-10-21

Conditions studied

Urinary Bladder, Underactive (1)

Sponsors

Astellas Pharma Europe B.V. (1)  ·  Astellas Pharma Inc (1)

Countries

Japan (2)  ·  Germany (1)  ·  Netherlands (1)  ·  Poland (1)  ·  Slovakia (1)  ·  United Kingdom (1)

Results publications

PMID 35419807

NIH funding

2017 (1)